[1]

Jayaram H, Kolko M, Friedman DS, Gazzard G. 2023. Glaucoma: now and beyond. The Lancet 402:1788−1801

doi: 10.1016/S0140-6736(23)01289-8
[2]

Selvan H, Gupta S, Wiggs JL, Gupta V. 2022. Juvenile-onset open-angle glaucoma – a clinical and genetic update. Survey of Ophthalmology 67:1099−1117

doi: 10.1016/j.survophthal.2021.09.001
[3]

Quigley HA. 2006. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 90:262−267

doi: 10.1136/bjo.2005.081224
[4]

Steinmetz JD. 2021. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Global Health 9:E144−E160

doi: 10.1016/S2214-109X(20)30489-7
[5]

Weinreb RN, Aung T, Medeiros FA. 2014. The pathophysiology and treatment of glaucoma a review. Jama 311:1901−1911

doi: 10.1001/jama.2014.3192
[6]

Michels TC, Ivan O. 2023. Glaucoma: diagnosis and management. American Family Physician 107:253−262
[7]

Nakano M, Ikeda Y, Taniguchi T, Yagi T, Fuwa M, et al. 2009. Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proceedings of the National Academy of Sciences of the United States of America 106:12838−12842

doi: 10.1073/pnas.0906397106
[8]

Wang Z, Wiggs JL, Aung T, Khawaja AP, Khor CC. 2022. The genetic basis for adult onset glaucoma: Recent advances and future directions. Progress in Retinal and Eye Research 90:101066

doi: 10.1016/j.preteyeres.2022.101066
[9]

Mabuchi F, Mabuchi N, Sakurada Y, Yoneyama S, Kashiwagi K, et al. 2020. Genetic variants associated with the onset and progression of primary open-angle glaucoma. American Journal of Ophthalmology 215:135−140

doi: 10.1016/j.ajo.2020.03.014
[10]

Gharahkhani P, Jorgenson E, Hysi P, Khawaja AP, Pendergrass S, et al. 2021. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nature Communications 12:1258

doi: 10.1038/s41467-020-20851-4
[11]

Ying Y, Xue R, Yang Y, Zhang SX, Xiao H, et al. 2021. Activation of ATF4 triggers trabecular meshwork cell dysfunction and apoptosis in POAG. Aging 13:8628−8642

doi: 10.18632/aging.202677
[12]

Lieberman RL, Ma MT. 2021. Molecular insights into myocilin and its glaucoma-causing misfolded olfactomedin domain variants. Accounts of Chemical Research 54:2205−2215

doi: 10.1021/acs.accounts.1c00060
[13]

Ticho U, Durst A, Licht A, Berkowitz S. 1977. Steroid-induced glaucoma and cataract in renal-transplant recipients. Israel Journal of Medical Sciences 13:871−874
[14]

Patel PD, Kodati B, Clark AF. 2023. Role of glucocorticoids and glucocorticoid receptors in glaucoma pathogenesis. Cells 12:2452

doi: 10.3390/cells12202452
[15]

Rüfer F, Uthoff D. 2013. Symptoms and therapy for steroid glaucoma. Klinische Monatsblatter Fur Augenheilkunde 230:692−696

doi: 10.1055/s-0032-1328472
[16]

Danias J, Gerometta R, Ge Y, Ren L, Panagis L, et al. 2011. Gene expression changes in steroid-induced IOP elevation in bovine trabecular meshwork. Investigative Opthalmology & Visual Science 52:8636−8645

doi: 10.1167/iovs.11-7563
[17]

Liu Y, Allingham RR, Qin X, Layfield D, Dellinger AE, et al. 2013. Gene expression profile in human trabecular meshwork from patients with primary open-angle glaucoma. Investigative Ophthalmology & Visual Science 54:6382−6389

doi: 10.1167/iovs.13-12128
[18]

Safran M, Dalah I, Alexander J, Rosen N, Stein TI, et al. 2010. GeneCards Version 3: the human gene integrator. Database 2010:baq020

doi: 10.1093/database/baq020
[19]

Hu J, Szymczak S. 2023. A review on longitudinal data analysis with random forest. Briefings in Bioinformatics 24:bbad002

doi: 10.1093/bib/bbad002
[20]

Miao YR, Zhang Q, Lei Q, Luo M, Xie GY, et al. 2020. ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy. Advanced Science 7:1902880

doi: 10.1002/advs.201902880
[21]

Dai Q, Zhao S, Li J, Li N, Wang A, et al. 2025. Integration of single-cell and bulk transcriptomics reveals β-hydroxybutyrylation-related signatures in primary open-angle glaucoma. Experimental Eye Research 254:110272

doi: 10.1016/j.exer.2025.110272
[22]

Hamel AR, Yan W, Rouhana JM, Monovarfeshani A, Jiang X, et al. 2024. Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma. Nature Communications 15:396

doi: 10.1038/s41467-023-44380-y
[23]

Xiao J, Zhao C, Liang A, Zhang M, Cheng G. 2021. Efficacy and safety of high-energy selective laser trabeculoplasty for steroid-induced glaucoma in patients with quiescent uveitis. Ocular Immunology and Inflammation 29:766−770

doi: 10.1080/09273948.2019.1687730
[24]

Shinozaki Y, Kashiwagi K, Koizumi S. 2023. Astrocyte immune functions and glaucoma. International Journal of Molecular Sciences 24:2747

doi: 10.3390/ijms24032747
[25]

van Zyl T, Yan W, McAdams A, Peng YR, Shekhar K, et al. 2020. Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis. Proceedings of the National Academy of Sciences of the United States of America 117:10339−10349

doi: 10.1073/pnas.2001250117
[26]

Wu J, Wang C, Sun S, Ren T, Pan L, et al. 2024. Single-cell transcriptomic Atlas of aging macaque ocular outflow tissues. Protein & Cell 15:594−611

doi: 10.1093/procel/pwad067
[27]

Grün D, van Oudenaarden A. 2015. Design and analysis of single-cell sequencing experiments. Cell 163:799−810

doi: 10.1016/j.cell.2015.10.039
[28]

Hysi PG, Hammond CJ. 2025. An ocular gene-set expression library for heritability partition and cell line enrichment analyses. Investigative Ophthalmology & Visual Science 66:11

doi: 10.1167/iovs.66.3.11
[29]

Rong S, Yu X, Wiggs JL. 2024. Genetic basis of pigment dispersion syndrome and pigmentary glaucoma: an update and functional insights. Genes 15:142

doi: 10.3390/genes15020142
[30]

Liesenborghs I, Schouten JSAG, Kutmon M, Gorgels TGMF, Evelo CT, et al. 2022. A systematically derived overview of the non-ubiquitous pathways and genes that define the molecular and genetic signature of the healthy trabecular meshwork. Genomics 114:110280

doi: 10.1016/j.ygeno.2022.110280
[31]

Wan P, Huang S, Luo Y, Deng C, Zhou J, et al. 2022. Reciprocal regulation between lncRNA ANRIL and p15 in steroid-induced glaucoma. Cells 11:1468

doi: 10.3390/cells11091468
[32]

Zanon-Moreno V, Ortega-Azorin C, Asensio-Marquez EM, Garcia-Medina JJ, Pinazo-Duran MD, et al. 2017. A multi-locus genetic risk score for primary open-angle glaucoma (POAG) variants is associated with POAG risk in a Mediterranean population: inverse correlations with plasma vitamin C and E concentrations. International Journal of Molecular Sciences 18:2302

doi: 10.3390/ijms18112302
[33]

Yang Z, Yang J, Liu D, Yu W. 2021. Mendelian randomization analysis identified genes pleiotropically associated with central corneal thickness. BMC Genomics 22:517

doi: 10.1186/s12864-021-07860-3
[34]

Cordeiro MF, Gandolfi S, Gugleta K, Normando EM, Oddone F. 2024. How latanoprost changed glaucoma management. Acta Ophthalmologica 102:e140−e155

doi: 10.1111/aos.15725
[35]

Xu W, Sun Y, Zhao S, Zhao J, Zhang J. 2023. Identification and validation of autophagy-related genes in primary open-angle glaucoma. BMC Medical Genomics 16:287

doi: 10.1186/s12920-023-01722-5
[36]

Han DT, Zhao W, Powell WH. 2022. Dioxin disrupts thyroid hormone and glucocorticoid induction of klf9, a master regulator of frog metamorphosis. Toxicological Sciences 187:150−161

doi: 10.1093/toxsci/kfac017
[37]

Suo L, Dai W, Qin X, Li G, Zhang D, et al. 2022. Screening of primary open-angle glaucoma diagnostic markers based on immune-related genes and immune infiltration. BMC Genomic Data 23:67

doi: 10.1186/s12863-022-01072-8
[38]

Fan X, Kennedy S, Bilir EK, Lane B, Kingston OA, et al. 2025. Transcriptome profiling of trabecular meshwork progenitor cells. Stem Cell Reviews and Reports 21:1776−1797

doi: 10.1007/s12015-025-10900-0
[39]

Zhang X, Xiao L, Zhou X, Xu J, Liao L, et al. 2025. Identification of a chromatin regulator signature and potential candidate drugs for primary open-angle glaucoma. Epigenomics 17:377−387

doi: 10.1080/17501911.2025.2479420
[40]

Wirtz MK, Sykes R, Samples J, Edmunds B, Choi D, et al. 2022. Identification of missense extracellular matrix gene variants in a large glaucoma pedigree and investigation of the N700S thrombospondin-1 variant in normal and glaucomatous trabecular meshwork cells. Current Eye Research 47:79−90

doi: 10.1080/02713683.2021.1945109
[41]

Patel G, Fury W, Yang H, Gomez-Caraballo M, Bai Y, et al. 2020. Molecular taxonomy of human ocular outflow tissues defined by single-cell transcriptomics. Proceedings of the National Academy of Sciences of the United States of America 117:12856−12867

doi: 10.1073/pnas.2001896117
[42]

Wu E, He W, Wu C, Chen Z, Zhou S, et al. 2023. HSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation. Cell Research 33:851−866

doi: 10.1038/s41422-023-00859-3
[43]

Wang Y, Xu W, Zhou D, Neckers L, Chen S, et al. 2014. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex. Journal of Biological Chemistry 289:4815−4826

doi: 10.1074/jbc.M113.518480
[44]

Patel GC, Millar JC, Clark AF. 2019. Glucocorticoid receptor transactivation is required for glucocorticoid-induced ocular hypertension and glaucoma. Investigative Ophthalmology & Visual Science 60:1967−1978

doi: 10.1167/iovs.18-26383
[45]

Kirschke E, Goswami D, Southworth D, Griffin PR, Agard DA. 2014. Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell 157:1685−1697

doi: 10.1016/j.cell.2014.04.038
[46]

Clark AF, Steely HT, Dickerson JE, Jr, English-Wright S, Stropki K, et al. 2001. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Investigative Ophthalmology & Visual Science 42:1769−1780
[47]

Zhang X, Clark AF, Yorio T. 2005. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-β. Investigative Ophthalmology & Visual Science 46:4607−4616

doi: 10.1167/iovs.05-0571
[48]

Yemanyi F, Vranka J, Raghunathan VK. 2020. Glucocorticoid-induced cell-derived matrix modulates transforming growth factor β2 signaling in human trabecular meshwork cells. Scientific Reports 10:15641

doi: 10.1038/s41598-020-72779-w
[49]

Hu S, Ren S, Cai Y, Liu J, Han Y, et al. 2022. Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt-β-catenin-STAT3 signaling. Cell Death & Differentiation 29:642−656

doi: 10.1038/s41418-021-00880-2
[50]

Yarishkin O, Phuong TTT, Baumann JM, De Ieso ML, Vazquez-Chona F, et al. 2021. Piezo1 channels mediate trabecular meshwork mechanotransduction and promote aqueous fluid outflow. The Journal of Physiology 599:571−592

doi: 10.1113/jp281011
[51]

Ethier CR, Herberg S. 2025. Mechanobiology in the eye. npj Biological Physics and Mechanics 2:18

doi: 10.1038/s44341-025-00022-6
[52]

Stumpff F, Wiederholt M. 2000. Regulation of trabecular meshwork contractility. Ophthalmologica 214:33−53

doi: 10.1159/000027471
[53]

Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: structures, properties, and functions. Physiological Reviews 79:1193−1226

doi: 10.1152/physrev.1999.79.4.1193
[54]

Bouhenni RA, Al Shahwan S, Morales J, Wakim BT, Chomyk AM, et al. 2011. Identification of differentially expressed proteins in the aqueous humor of primary congenital glaucoma. Experimental Eye Research 92:67−75

doi: 10.1016/j.exer.2010.11.004
[55]

Perumal N, Manicam C, Steinicke M, Funke S, Pfeiffer N, et al. 2017. Characterization of the human aqueous humour proteome: A comparison of the genders. PLoS One 12:e0172481

doi: 10.1371/journal.pone.0172481
[56]

Tavares-Ferreira D, Ray PR, Sankaranarayanan I, Mejia GL, Wangzhou A, et al. 2022. Sex differences in nociceptor translatomes contribute to divergent prostaglandin signaling in male and female mice. Biological Psychiatry 91:129−140

doi: 10.1016/j.biopsych.2020.09.022
[57]

Wu E, Wu C, Jia K, Zhou SA, Sun L. 2024. HSPA8 inhibitors augment cancer chemotherapeutic effectiveness via potentiating necroptosis. Molecular Biology of the Cell 35:ar108

doi: 10.1091/mbc.E24-04-0194
[58]

Zhu X, Zeng B, Wu C, Chen Z, Yu M, et al. 2023. Inhibition of TGF-β2-induced trabecular meshwork fibrosis by pirfenidone. Translational Vision Science & Technology 12:21

doi: 10.1167/tvst.12.11.21
[59]

Cho YS, Yen CN, Shim JS, Kang DH, Kang SW, et al. 2016. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway. Scientific Reports 6:34655

doi: 10.1038/srep34655
[60]

Yuan QM, Liu XN, Qiu LY, Zhang YF, Yuan HP. 2025. The role of the HIF-1 signaling pathway in retinal ganglion cell injury caused by the OPTN (E50K) mutation. Chinese Journal of Ophthalmology 61:686−696 (in Chinese)

doi: 10.3760/cma.j.cn112142-20250526-00248
[61]

Tabak S, Schreiber-Avissar S, Beit-Yannai E. 2021. Crosstalk between microRNA and oxidative stress in primary open-angle glaucoma. International Journal of Molecular Sciences 22:2421

doi: 10.3390/ijms22052421
[62]

Mondal S, Roy D, Sarkar Bhattacharya S, Jin L, Jung D, et al. 2019. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. International Journal of Cancer 144:178−189

doi: 10.1002/ijc.31868
[63]

Sasaki M, Sato Y, Nakanuma Y. 2020. Increased p16INK4a-expressing senescent bile ductular cells are associated with inadequate response to ursodeoxycholic acid in primary biliary cholangitis. Journal of Autoimmunity 107:102377

doi: 10.1016/j.jaut.2019.102377